Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing.
Sadeghi HM, Adeli I, Calina D, Docea AO, Mousavi T, Daniali M, Nikfar S, Tsatsakis A, Abdollahi M. · 2022
Read Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing. by Sadeghi HM, Adeli I, Calina D, Docea AO, Mousavi T, Daniali M, Nikfar S, Tsatsakis A, Abdollahi M. (2022) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8775814.txt.
Description
Sadeghi and co-authors give a comprehensive review of polycystic ovary syndrome, from its causes to drug repurposing. This hormone and reproductive disorder affects many women of childbearing age. Its exact cause is still not fully known. The team searched medical and trial databases for work on causes, care, and reused drugs.
Outside factors include gene regulation, toxic exposures, stress, and diet. Inside factors span insulin resistance, excess androgens, inflammation, and obesity. Lifestyle change and added therapies often come first in care. Many drug classes built for other diseases show promise here. Few trials are complete, though, and most are small. More research is urged.
Catalog record
| CREATOR | Sadeghi HM, Adeli I, Calina D, Docea AO, Mousavi T, Daniali M, Nikfar S, Tsatsakis A, Abdollahi M. |
|---|---|
| YEAR | 2022 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 74 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |